中文版普适性药物依从性量表在非结核分枝杆菌肺病患者中的信效度分析  

Reliability and validity analysis of the Chinese version of the general medication adherence scale in patients with nontuberculous mycobacterial pulmonary disease

作　　者：毛昕妍 储美萍 王婷 MAO Xin-yan;CHU Mei-ping;WANG Ting(School of Medicine,Jiangnan University,Wuxi,Jiangsu 214000,China;不详)

机构地区：[1]江南大学医学院,江苏无锡214000 [2]无锡市第五人民医院(江南大学附属无锡五院)呼吸与危重症医学科

出　　处：《现代预防医学》2025年第4期603-607,共5页Modern Preventive Medicine

摘　　要：目的检验中文版普适性药物依从性量表(general medication adherence scale,GMAS)在非结核分枝杆菌肺病(Nontuberculous mycobacteria pulmonary disease,NTM-PD)患者中的信度与效度。方法选取2023年2月至2024年9月在江南大学附属无锡五院就诊的NTM-PD患者作为研究对象进行问卷调查,以检验中文版GMAS的信效度。结果研究共纳入281例患者。中文版GMAS的Cronbachα系数为0.890,各维度Cronbachα系数为0.834~0.890。折半信度为0.806,各维度折半信度为0.834~0.870,重测信度为0.896。探索性因子分析供提取3个公因子,累计方差贡献率为76.244%。验证性因子分析显示模型拟合度良好,χ^(2)/df=1.583,GFI=0.928,AGFI=0.884,NFI=0.934,TLI=0.965,CFI=0.974,TLI=0.965,RMSEA=0.063,且具有较好的聚敛效度和区分效度。结论中文版GMAS在以中老年人群为主的NTM-PD患者中具有良好的信度和效度,可用于评估此人群的用药依从性水平。Objective To test the reliability and validity of the Chinese version of the general medication adherence scale(GMAS)in patients with nontuberculous mycobacterial pulmonary disease(NTM-PD).Methods Patients with NTM-PD treated in Wuxi Fifth Hospital affiliated with Jiangnan University from February 2023 to September 2024 were selected as research objects to conduct a questionnaire survey to test the reliability and validity of the Chinese version of GMAS.Results A total of 281 patients were included in the study.The Cronbach'sαcoefficient of the Chinese version of the universal medication compliance scale was 0.890,and the Cronbach'sαcoefficient of each dimension was 0.834-0.890.The broken half reliability was 0.806,the split-half reliability of each dimension was 0.834-0.870,and the test-retest reliability was 0.896.Three common factors were extracted by exploratory factor analysis,and the cumulative variance contribution rate was 76.244%.Confirmatory factor analysis showed that the model had a good fit,χ^(2)/df=1.583,GFI=0.928,AGFI=0.884,NFI=0.934,TLI=0.965,CFI=0.974,TLI=0.965,RMSEA=0.063,and had good convergent validity and discriminant validity.Conclusion The Chinese version of GMAS has good reliability and validity in NTM-PD patients,mainly middle-aged and elderly people,and can be used to evaluate the level of medication compliance in this population.

关 键 词：普适性药物依从性量表 非结核分枝杆菌肺病 用药依从性 信效度研究 

分 类 号：R195.1[医药卫生—卫生统计学]